 Safety pharmacokinetics rimantadine small-particle aerosol safety pharmacokinetics rimantadine small-particle aerosol healthy adults adults acute influenza virus infection Aerosolized rimantadine concentration micrograms/liter air nasal burning irritation normal volunteers concentration micrograms/liter air normal volunteers changes pulmonary function routine spirometry plethysmography diffusion capacity carbon monoxide Mean peak levels drug serum aerosol administration oral administration mg versus ng/ml mean nasal wash levels versus ng/ml Elimination half-lives similar aerosol oral administration urinary excretion groups Twenty micrograms aerosolized rimantadine liter air daily days adults acute influenza virus infection Levels plasma aerosol inhalation similar normal volunteers end third treatment end first treatment versus ng/ml rimantadine small-particle aerosol dose micrograms/liter air normal volunteers acute influenza high local concentrations